Literature DB >> 15556527

Determination of linezolid in plasma and bronchoalveolar lavage by high-performance liquid chromatography with ultraviolet detection using a fully automated extraction method.

Jérôme Toutain1, Emmanuel Boselli, Sarah Djabarouti, Bernard Allaouchiche, Fabien Xuereb, Jean-Marc Bernadou, Boubakar Ba, Marie-Claude Saux, Dominique Breilh.   

Abstract

The aim of this study was to develop a specific and sensitive high-performance liquid chromatographic assay for the determination of linezolid in human plasma, and bronchoalveolar lavage. The sample extraction was based on a fully automated solid-phase extraction with an OASIS HLB cartridge. The method used ultraviolet detection set at a wavelength of 254 nm and a separation with a Zorbax Eclipse XDB C8 column. The assay has been found linear over the concentration range 0.02-30 microg/ml and 0.04-30 microg/ml for linezolid, respectively, in plasma and bronchoalveolar lavage. It provided good validation data for accuracy and precision (CV <4.64% and 5.08%, accuracy in the range 96.93-102.67% and 97.33-105.67%, respectively, for intra- and inter-day). The assay will be applied to determine the penetration of linezolid in human bronchoalveolar lavage during pharmacokinetic steady-state.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15556527     DOI: 10.1016/j.jchromb.2004.09.030

Source DB:  PubMed          Journal:  J Chromatogr B Analyt Technol Biomed Life Sci        ISSN: 1570-0232            Impact factor:   3.205


  6 in total

1.  Therapeutic drug monitoring of antimicrobials.

Authors:  Jason A Roberts; Ross Norris; David L Paterson; Jennifer H Martin
Journal:  Br J Clin Pharmacol       Date:  2012-01       Impact factor: 4.335

2.  Comparison of the pharmacokinetics of linezolid in burn and non-burn rabbits.

Authors:  Jian-Li Ma; Lei Gao; Xiang Li; Wan-Li Chu; Yong-Qiang Feng; Xiao-Qin Wang; Qing-Zhe Zhang
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2014-06-13       Impact factor: 2.441

3.  Linezolid in the Starter Combination for Multidrug-Resistant Tuberculosis: Time to Move on to Group Four?

Authors:  Soazic Grard; Gaud Catho; Florent Valour; Anissa Bouaziz; Thomas Perpoint; Evelyne Braun; François Biron; Patrick Miailhes; Tristan Ferry; Christian Chidiac; Pierre-Jean Souquet; Sébastien Couraud; Gérard Lina; Sylvain Goutelle; Nicolas Veziris; Oana Dumitrescu; Florence Ader
Journal:  Open Forum Infect Dis       Date:  2015-12-22       Impact factor: 3.835

4.  A validated stability-indicating LC method for the separation of enantiomer and potential impurities of Linezolid using polar organic mode.

Authors:  T Satyanarayana Raju; O Vishweshwari Kutty; V Ganesh; P Yadagiri Swamy
Journal:  J Pharm Anal       Date:  2012-03-18

5.  Development and Validation of an HPLC-UV Method for Quantitation of Linezolid: Application to Resistance Study Using in vitro PK/PD Model.

Authors:  Guang Yang; Yisong Yan; Jun Mao; Huiping Liu; Mingtao Chen; Na Zhang; Yaowen Li; Jiangjun Gu; Xiaohui Huang
Journal:  Infect Drug Resist       Date:  2021-12-01       Impact factor: 4.003

6.  Pharmacokinetics and Pharmacodynamics of Anti-infective Agents during Continuous Veno-venous Hemofiltration in Critically Ill Patients: Lessons Learned from an Ancillary Study of the IVOIRE Trial.

Authors:  Dominique Breilh; Patrick M Honore; David De Bels; Jason A Roberts; Jean Baptiste Gordien; Catherine Fleureau; Antoine Dewitte; Julien Coquin; Hadrien Rozé; Paul Perez; Rachid Attou; Sebastien Redant; Luc Kugener; Marie-Claude Saux; Herbert D Spapen; Alexandre Ouattara; Olivier Joannes-Boyau
Journal:  J Transl Int Med       Date:  2019-12-31
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.